J acobsen et al.
) 5.6, 16.4 Hz, 1H), 3.76-3.80 (m, 1H), 4.04-4.09 (m, 2H),
4.13-4.23 (m, 5H), 4.62 (br s, 1H); 13C NMR (100 MHz, CDCl3)
δ 14.2 (2C), 15.0, 18.0, 27.3, 36.1, 58.8, 61.2, 61.6, 61.7, 62.9,
158.9, 170.6, 171.3; MS (electrospray) m/z 339.2 (M + Na);
HRMS m/e calcd for C14H24N2NaO6 (M + Na) 339.1532, found
339.1537.
(S)-Eth yl 2-((S)-4-Isopr opyl-2-oxooxazolidin -3-ylam in o)-
4-oxo-4-(p h en ylth io)bu ta n oa te (2d ). Data for major dias-
tereomer: 1H NMR (400 MHz, CDCl3) δ 0.85 (d, J ) 7.2 Hz,
3H), 0.89 (d, J ) 7.2 Hz, 3H), 1.29 (t, J ) 6.8 Hz, 3H), 2.21-
2.30 (m, 1H), 3.08 (dd, J ) 7.2, 16.0 Hz, 1H), 3.15 (dd, J )
5.2, 16.0 Hz, 1H), 3.72-3.76 (m, 1H), 4.04 (dd, J ) 4.4, 8.8
Hz, 1H), 4.09-4.24 (m, 4H), 4.62 (br s, 1H), 7.39-7.42 (m, 5H);
13C NMR (100 MHz, CDCl3) δ 14.2, 15.0, 17.9, 27.2, 44.5, 58.7,
61.1, 61.2, 62.9, 127.2, 129.4 (2C), 129.8 (2C), 134.6, 158.8,
170.8, 194.8; MS (electrospray) m/z 403.2 (M + Na); HRMS
m/e calcd for C18H24N2NaO5S (M + Na) 403.1304, found
403.1303.
J ) 5.5, 16.4 Hz, 1H), 3.36 (dd, J ) 3.2, 16.4 Hz, 1H), 3.96-
4.03 (m, 2H), 4.07-4.12 (m, 1H), 4.18-4.28 (m, 3H), 4.76 (d,
J ) 5.5 Hz, 1H), 7.16-7.34 (m, 5H); 13C NMR (100 MHz,
CDCl3) δ 14.2, 14.8, 23.8, 44.7, 59.2, 59.3, 61.8, 66.5, 127.2,
129.1 (2C), 129.2 (2C), 135.9, 158.7, 171.1, 196.3; MS (elec-
trospray) m/z 403.2 (M + Na); HRMS m/e calcd for C18H24N2-
NaO5S (M + Na) 403.1304, found 403.1304.
(S)-Eth yl 2-((S)-4-Ben zyl-2-oxooxa zolid in -3-yla m in o)-
5,5-d im eth yl-4-oxoh exa n oa te (2i). Data for major diaste-
reomer: 1H NMR (400 MHz, CDCl3) δ 1.30 (t, J ) 7.1 Hz, 3H),
1.47 (s, 9H), 2.58-2.64 (m, 1H), 2.71 (dd, J ) 4.0, 16.4 Hz,
1H), 2.76 (dd, J ) 6.0, 16.4 Hz, 1H), 3.38 (dd, J ) 3.2, 13.2
Hz, 1H), 3.99-4.06 (m, 2H), 4.07-4.14 (m, 2H), 4.19-4.29 (m,
2H), 4.79 (d, J ) 4.4 Hz, 1H), 7.17-7.34 (m, 5H); 13C NMR
(100 MHz, CDCl3) δ 14.3, 28.2 (3C), 37.1, 37.2, 59.0, 59.4, 61.6,
66.5, 81.7, 127.2, 129.0 (2C), 129.2 (2C), 135.9, 158.8, 169.7,
171.3; MS (electrospray) m/z 415.2 (M + Na); HRMS m/e calcd
for C20H28N2NaO6 (M + Na) 415.1845, found 415.1832.
(S)-Dieth yl 2,2-Dim eth yl-3-((S)-2-oxo-4-p h en yloxa zo-
lid in -3-yla m in o)su ccin a te (2e). Data for diastereomeric
mixture: 1H NMR (400 MHz, CDCl3) δ 1.01 (s, 3H, minor
diastereomer), 1.02 (s, 3H, minor diastereomer), 1.07 (s, 3H,
major diastereomer), 1.15 (s, 3H, major diastereomer), 1.19
(t, J ) 7.2 Hz, 3H, major diastereomer), 1.20 (t, J ) 7.2 Hz,
3H, minor diastereomer), 1.25 (t, J ) 7.2 Hz, 3H, minor
diastereomer), 1.26 (t, J ) 7.2 Hz, 3H, major diastereomer),
3.47 (d, J ) 7.6 Hz, 1H, minor diastereomer), 3.85 (s, 1H, major
diastereomer), 3.99-4.09 (m, 4H), 4.11-4.19 (m, 6H), 4.53 (t,
J ) 8.8 Hz, 1H, minor diastereomer), 4.59 (t, J ) 8.4 Hz, 1H,
major diastereomer), 4.72-4.84 (m, 4H), 7.24-7.27 (m, 2H),
7.34-7.45 (m, 8H); 13C NMR (100 MHz, CDCl3) δ 14.1, 14.2,
20.9, 21.8, 22.1, 22.3, 46.2, 60.9, 61.0, 61.4, 61.5, 62.9, 68.4,
68.9 (2C), 69.3, 127.1 (2C), 127.9 (2C), 128.9, 129.1 (2C), 129.2
(2C), 129.4, 136.8, 138.1, 157.9, 158.3, 171.7 (2C), 175.3, 175.8;
MS (electrospray) m/z 401.2 (M + Na); HRMS m/e calcd for
(S)-Dieth yl 3-Ben za m id o-2,2-d im eth ylsu ccin a te (6). To
a solution of the hydrazine 2a (91 mg, 0.23 mmol) in THF (2.0
mL) was added dropwise n-BuLi (158 µL, 1.6 M in hexanes,
0.25 mmol) at -78 °C. The resulting mixture was stirred for
40 min at -78 °C. Benzoyl chloride (35 µL, 0.30 mmol) was
added dropwise and the reaction mixture was allowed to warm
to room temperature. Saturated aqueous NH4Cl (2.0 mL) was
added and the aqueous phase was extracted several times with
CH2Cl2. The combined organics were dried over MgSO4 and
evaporated to dryness in vacuo. The crude product was
redissolved in MeOH (2.5 mL) and SmI2 solution was added
dropwise (6.0 mL, 0.60 mmol, 0.1 M in THF) at room temper-
ature. The resulting solution was stirred for 5 min and
saturated aqueous NH4Cl (2.0 mL) was added. The organic
solvents were removed by evaporation in vacuo and the
aqueous phase was extracted with CH2Cl2. The combined
organic phases were dried over MgSO4 and evaporated to
dryness in vacuo. The residue was subjected to column
chromatography (pentanes/EtOAc, gradient elution) on silica
gel. This afforded 35 mg (65%) of 6, followed by 29 mg (70%)
of 5a .19 Data for 6: 1H NMR (400 MHz, CDCl3) δ 1.27 (t, J )
6.8 Hz, 3H), 1.31 (t, J ) 7.2 Hz, 3H), 1.37 (s, 6H), 4.16-4.26
(m, 4H), 5.04 (d, J ) 9.2 Hz, 1H), 7.23 (d, J ) 9.2 Hz, 1H),
C
19H26N2NaO6 (M + Na) 401.1689, found 401.1688.
(S)-Dieth yl 2-((S)-4-Ben zyl-2-oxooxa zolid in -3-yla m in o-
)su ccin a te (2f). Data for major diastereomer: 1H NMR (400
MHz, CDCl3) δ 1.27 (t, J ) 7.0 Hz, 3H), 1.30 (t, J ) 7.0 Hz,
3H), 2.61 (dd, J ) 9.4, 13.3 Hz, 1H), 2.78 (dd, J ) 7.0, 16.4
Hz, 1H), 2.84 (dd, J ) 5.5, 16.4 Hz, 1H), 3.37 (dd, J ) 3.6,
12.5 Hz, 1H), 3.97-4.05 (m, 2H), 4.08-4.30 (m, 6H), 4.80 (d,
J ) 3.9 Hz, 1H), 7.16-7.34 (m, 5H); 13C NMR (100 MHz,
CDCl3) δ 14.2, 14.3, 36.0, 37.3, 59.0, 59.4, 61.2, 61.7, 66.6,
127.2, 129.1 (2C), 129.2 (2C), 135.9, 158.8, 170.6, 171.2; MS
(electrospray) m/z 387.2 (M + Na); HRMS m/e calcd for
7.44-7.48 (m, 2H), 7.51-7.55 (m, 1H), 7.82-7.84 (m, 2H); 13
C
NMR (100 MHz, CDCl3) δ 14.2, 22.9, 23.2, 45.5, 58.5, 61.4,
61.8, 127.2 (2C), 128.8 (2C), 132.0, 134.1, 167.3, 170.6, 175.8;
MS (electrospray) m/z 344.2 (M + Na); HRMS m/e calcd for
C
18H24N2NaO6 (M + Na) 387.1532, found 387.1527.
(S)-Eth yl 2-((S)-4-Ben zyl-2-oxooxa zolid in -3-yla m in o)-
C
17H23NNaO5 (M + Na) 344.1474, found 344.1469.
4-oxo-4-(p h en ylth io)bu ta n oa te (2g). Data for major dias-
tereomer: 1H NMR (400 MHz, CDCl3) δ 1.31 (t, J ) 7.0 Hz,
3H), 2.61 (dd, J ) 9.4, 13.3 Hz, 1H), 3.11 (dd, J ) 7.0, 16.4
Hz, 1H), 3.18 (dd, J ) 5.5, 16.4 Hz, 1H), 3.35 (dd, J ) 3.1,
13.3 Hz, 1H), 3.94-4.11 (m, 3H), 4.18-4.31 (m, 3H), 4.77 (d,
J ) 4.7 Hz, 1H), 7.15-7.33 (m, 5H), 7.39-7.43 (m, 5H); 13C
NMR (100 MHz, CDCl3) δ 14.2, 37.2, 44.4, 59.0, 59.0, 61.9,
66.5, 127.2 (2C), 129.1 (2C), 129.2 (2C), 129.5 (2C), 129.8 (2C),
134.6, 135.8, 158.7, 170.8, 194.7; MS (electrospray) m/z 451.2
(M + Na); HRMS m/e calcd for C22H24N2NaO5S (M + Na)
451.1304, found 451.1307.
(S)-Eth yl 2-((S)-4-Ben zyl-2-oxooxa zolid in -3-yla m in o)-
4-(eth ylth io)-4-oxobu ta n oa te (2h ). Data for major diaste-
reomer: 1H NMR (400 MHz, CDCl3) δ 1.26 (t, J ) 7.0 Hz, 3H),
1.30 (t, J ) 7.0 Hz, 3H), 2.61 (dd, J ) 10.2, 13.3 Hz, 1H), 2.92
(q, J ) 7.0 Hz, 2H), 3.00 (dd, J ) 7.0, 16.4 Hz, 1H), 3.06 (dd,
Ack n ow led gm en t. We thank Dr. Rita Hazell for
X-ray analysis. We are indebted to the Danish National
Science Research Council, the University of Aarhus, and
the LEO Pharma Research Foundation for generous
financial support.
Su p p or tin g In for m a tion Ava ila ble: General experimen-
1
tal methods, spectroscopic data for 3a -c, copies of H NMR
and 13C NMR spectra for compounds 2a -i and 6, and single-
crystal X-ray structure and crystallographic data for 2a . This
material is available free of charge via the Internet at
http://pubs.acs.org.
J O0358170
(16) (a) Kobayashi, S.; Manabe, K. Tetrahedron Lett. 1999, 40, 3773.
(b) Kobayashi, S.; Busujima, T.; Nagayama, S. Synlett 1999, 545.
(17) Minor amounts of the 2-oxazolidinone and the corresponding
unsaturated ester were also detected (1H NMR) in the case of the ZnCl2-
mediated reaction of 4b and 3a (Table 3, entry 3). The exact reasons
for this apparent deviation of 4b from the other silyl enolates are
unknown.
(18) For spectroscopic data for 2-hydroxybut-2-enedioic acid diethyl
ester (9), see: Chrystal, E. J . T.; Couper, L.; Robins, D. J . Tetrahedron
1995, 37, 10241.
(19) Wu, Y.; Shen, X. Tetrahedron: Asymmetry 2000, 11, 4359.
4796 J . Org. Chem., Vol. 69, No. 14, 2004